SAM
CLBT icon

Smartleaf Asset Management’s Cellebrite CLBT Stock Holding History

Smartleaf Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Hold
118
– – ﹤0.01% 2991
2026
Q1 		$1.56K Hold
118
– – ﹤0.01% 3026
2025
Q4 		$2.12K Buy
+118
New +$2.12K ﹤0.01% 2973

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Smartleaf Asset Management's CLBT Position: Q2 2026 in Review

Smartleaf Asset Management held its Cellebrite (CLBT) position steady in Q2 2026 at 118 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2991.

Smartleaf Asset Management first reported a position in CLBT in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.12K in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Smartleaf Asset Management held 118 shares of Cellebrite worth $1.67K as of Q2 2026.
  • Smartleaf Asset Management left its Cellebrite share count unchanged in Q2 2026.
  • Cellebrite made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2991 holding.
  • Smartleaf Asset Management first reported a position in Cellebrite in Q4 2025 and has held it in 3 quarters since.
  • Smartleaf Asset Management's Cellebrite position peaked at $2.12K in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.